MGMT gene silencing by promoter hypermethylation in gastric cancer in a high incidence area.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 4, p. 245, doi. 10.1007/s13402-014-0179-3
- By:
- Publication type:
- Article
Works matching IS 22113428 AND DT 2014 AND VI 37 AND IP 4
Results: 7
1
2
eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 4, p. 253, doi. 10.1007/s13402-014-0181-9
- By:
- Publication type:
- Article
3
ARID3B expression in primary breast cancers and breast cancer-derived cell lines.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 4, p. 289, doi. 10.1007/s13402-014-0185-5
- By:
- Publication type:
- Article
4
A novel CDC73 gene mutation in an Italian family with hyperparathyroidism-jaw tumour (HPT-JT) syndrome.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 4, p. 281, doi. 10.1007/s13402-014-0187-3
- By:
- Publication type:
- Article
5
Validation of DNA promoter hypermethylation biomarkers in breast cancer - a short report.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 4, p. 297, doi. 10.1007/s13402-014-0189-1
- By:
- Publication type:
- Article
6
Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 4, p. 235, doi. 10.1007/s13402-014-0178-4
- By:
- Publication type:
- Article
7
Translational suppression of HIF-1α by miconazole through the mTOR signaling pathway.
- Published in:
- Cellular Oncology (2211-3428), 2014, v. 37, n. 4, p. 269, doi. 10.1007/s13402-014-0182-8
- By:
- Publication type:
- Article